Advertisement

Topics

Mustang Bio Announces $12.8 Million Grant To Fund Phase I Trial Of CAR T Therapy MB-101 In Malignant Glioma

20:00 EDT 10 Oct 2017 | BioSpace

- Mustang research partner City of Hope awarded California Institute for Regenerative Medicine grant to support ongoing Phase 1 study NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang) (NASDAQ:MBIO), a Fortress Biotech, Inc. (NASDAQ:

Original Article: Mustang Bio Announces $12.8 Million Grant To Fund Phase I Trial Of CAR T Therapy MB-101 In Malignant Glioma

NEXT ARTICLE

More From BioPortfolio on "Mustang Bio Announces $12.8 Million Grant To Fund Phase I Trial Of CAR T Therapy MB-101 In Malignant Glioma"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...